Clinical and immune modulating effects of casein glycomacropeptide on healthy adults and patients with ulcerative colitis.
2020.05.12 | Health Kommunikation
Date | Fri 15 May |
Time | 14:30 — 16:30 |
Location | Auditorium J116-113 |
Friday the 15th of May at 14.30 Pernille Glahn Wernlund defends her PhD-dissertation entitled: “Clinical and immune modulating effects of casein glycomacropeptide on healthy adults and patients with ulcerative colitis.”
The defence is public and take place at Auditorium J116-113.